Sequana Medical announces inclusion of alfapump® in German treatment guidelines (DGVS) for complications of liver cirrhosis

World News: . []

Sequana Medicals pump is LINK  commercialised in Europe for the treatment of refractory liver LINK  which is a key complication of liver cirrhosis with limited LINK  options and severely LINK  patients quality of life The poten tial of...

More news and information about Sequana Medical NV

Published By:

Globe Newswire: 06:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "sequana" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us